Skip to Content
Merck
  • Spectrophotometric determination of tizanidine and orphenadrine via ion pair complex formation using eosin Y.

Spectrophotometric determination of tizanidine and orphenadrine via ion pair complex formation using eosin Y.

Chemistry Central journal (2011-10-11)
Mohamed I Walash, Fathalla F Belal, Manal I Eid, Samah Abo El Abass Mohamed
ABSTRACT

A simple, sensitive and rapid spectrophotometric method was developed and validated for the determination of two skeletal muscle relaxants namely, tizanidine hydrochloride (I) and orphenadrine citrate (II) in pharmaceutical formulations. The proposed method is based on the formation of a binary complex between the studied drugs and eosin Y in aqueous buffered medium (pH 3.5). Under the optimum conditions, the binary complex showed absorption maxima at 545 nm for tizanidine and 542 nm for orphenadrine. The calibration plots were rectilinear over concentration range of 0.5-8 μg/mL and 1-12 μg/mL with limits of detection of 0.1 μg/mL and 0.3 μg/mL for tizanidine and orphenadrine respectively. The different experimental parameters affecting the development and stability of the complex were studied and optimized. The method was successfully applied for determination of the studied drugs in their dosage forms; and to the content uniformity test of tizanidine in tablets.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tizanidine hydrochloride, ≥98% (HPLC), powder
Orphenadrine citrate, European Pharmacopoeia (EP) Reference Standard